Chief & Presenting Author: Dr.Bharat Gurnani

Co Author(s): Dr.Kirandeep Kaur

Abstract

Aim:The study focuses on assessing the effectiveness of cellulose biosynthesis inhibitors (CBIs) and cellulase enzymes on Pythium cell wall. Methods:Extensive literature review substantiate the hypothesis and validate the use of CBIs and cellulase enzymes in treating this keratitis.The concept also delves into the molecular action mechanisms of these agents on the Pythium cell wall, exploring procurement and administration strategies as potential therapeutic options.Results:Pythium plant-like cell wall makes it potentially vulnerable to cellulose-targeting treatments, a strategy not applicable to fungal and animal cells.The study identifies CBIs and cellulase enzymes, as promising treatment alternatives, potentially outperforming the limited efficacy of conventional agents.Conclusion: Addressing the high rates of therapeutic keratoplasty, the study highlights CBIs and cellulase enzymes as potential revolutionary treatments.Future clinical trials are required to confirm these finding.